대사증후군을 가진 조현병 환자에서 활동기록기로 평가한 수면의 질과 신체 활동량
Actigraphic Measurement of Sleep Quality and Physical Activity of Schizophrenic Inpatients with Metabolic Syndrome
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives：The authors examined the association of sleep quality and metabolic syndrome (MetS) in schizophrenic patients using actigraphy. Methods：A total of 101 schizophrenic patients were included in this study. Fifty-four (53.4%) patients met the criteria of MetS. Self-assessment of subjective sleep quality, daytime sleepiness, physical activities were measured using Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS) and International Physical Activity Questionnaire (IPAQ), respectively. Objective sleep quality and physical activity were measured by Actigraph (ActiGraph wGT3X-BT). Results：Total time in bed (TIB) (p=0.032), sleep latency (SL) (p=0.001), wake after sleep onset (WASO) (p<0.001) and average awakening (p=0.015) were significantly longer in patients with MetS than those of non-MetS. Results of multiple logistic regression showed that long sleep latency (OR 7.876, 95% CI 1.519, p=0.014) and low sleep efficiency (OR 9.902, 95% CI 1.111, p=0.040) were high risk factors for MetS. Conclusion：This was the first study to find the correlations of sleep quality and MetS in schizophrenic patients by objective sleep measurements. Although long sleep latency and low sleep efficiency were associated with MetS in patients with schizophrenia, more extensive and complicated designed studies may be needed to the association of MetS and sleep problems in schizophrenic patients.
Abstract
Objectives：The authors examined the association of sleep quality and metabolic syndrome (MetS) in schizophrenic patients using actigraphy. Methods：A total of 101 schizophrenic patients were included in this study. Fifty-four (53.4%) patients met the criteria of MetS. Self-assessment of subjective sleep quality, daytime sleepiness, physical activities were measured using Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS) and International Physical Activity Questionnaire (IPAQ), respectively. Objective sleep quality and physical activity were measured by Actigraph (ActiGraph wGT3X-BT). Results：Total time in bed (TIB) (p=0.032), sleep latency (SL) (p=0.001), wake after sleep onset (WASO) (p<0.001) and average awakening (p=0.015) were significantly longer in patients with MetS than those of non-MetS. Results of multiple logistic regression showed that long sleep latency (OR 7.876, 95% CI 1.519, p=0.014) and low sleep efficiency (OR 9.902, 95% CI 1.111, p=0.040) were high risk factors for MetS. Conclusion：This was the first study to find the correlations of sleep quality and MetS in schizophrenic patients by objective sleep measurements. Although long sleep latency and low sleep efficiency were associated with MetS in patients with schizophrenia, more extensive and complicated designed studies may be needed to the association of MetS and sleep problems in schizophrenic patients.
참고문헌 (69)
- Saha S, "A systematic review of mortality in schizophrenia : is the differential mortality gap worsening over time", Arch Gen Psychiatry, 64, pp.1123~1131 (2007)
- Lambert TJ, "Medical comorbidity in schizophrenia", Med J Aust, 178(Suppl), pp.S67~S70 (2003)
- Laursen TM, "Life expectancy among persons with schizophrenia or bipolar affective disorder", Schizophr Res, 131, pp.101~104 (2011)
- Isomaa B, "Cardiovascular morbidity and mortality associated with the metabolic syndrome", Diabetes Care, 24, pp.683~689 (2001)
- DeFronzo RA, "Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease", Diabetes Care, 14, pp.173~194 (1991)
- Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute scientific statement: Executive Summary, 2005, pp.4, 198~203
- Mitchell AJ, "Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis", Schizophr Bull, 39, pp.306~318 (2013)
- 남윤영, "만성 정신분열병 환자들의 대사증후군과 관련된 임상 특징들", 대한정신약물학회지, 17(4), pp.335~341 (2006), 대한정신약물학회
- 이화영, "조현병, 조현정동장애 외래 환자들의 대사증후군 유병률", 대한조현병학회지, 15(1), pp.39~45 (2012), 대한조현병학회
- Kang K, "Prevalence of metabolic syndrome in chronic schizophrenic inpatients", J Korean Soc Biol Psychiatry, 18, pp.281~289 (2012)
- McCreadie R, "Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study", Bmj, 317, pp.784~785 (1998)
- Vancampfort D, "Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophrenia", Psychiatry Res, 207, pp.25~32 (2013)
- Sicras-Mainar A, "Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia", Neuropsychiatr Dis Treat, 11, pp.51~ (2015)
- Haupt DW, "Differential metabolic effects of antipsychotic treatments", Eur Neuropsychopharmacol, 16, pp.S149~S155 (2006)
- Krakowski M, "Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol", Schizophr Res, 110, pp.95~102 (2009)
- Rébecca Robillard, "Are Cardiometabolic and Endocrine Abnormalities Linked to Sleep Difficulties in Schizophrenia? A Hypothesis Driven Review", Clinical Psychopharmacology and Neuroscience, 10(1), pp.1~12 (2012), 대한정신약물학회[DOI]
- Kruisbrink M, "Association of sleep duration and quality with blood lipids : a systematic review and meta-analysis of prospective studies", BMJ Open, 7, pp.e018585~ (2017)
- Iftikhar IH, "Sleep Duration and Metabolic Syndrome. An Updated Dose-Risk Metaanalysis", Ann Am Thorac Soc, 12, pp.1364~1372 (2015)
- Xi B, "Short sleep duration predicts risk of metabolic syndrome : a systematic review and meta-analysis", Sleep Med Rev, 18, pp.293~297 (2014)
- Itani O, "Short sleep duration and health outcomes: a systematic review, metaanalysis, and meta-regression", Sleep Med, 32, pp.246~256 (2017)
- Ju SY, "Sleep duration and metabolic syndrome in adult populations : a meta-analysis of observational studies", Nutr Diabetes, 3, pp.e65~ (2013)
- Jike M, "Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression", Sleep Med Rev, 39, pp.25~36 (2018)
- Wang F, "Meta-analysis on night shift work and risk of metabolic syndrome", Obes Rev, 15, pp.709~720 (2014)
- Haffmans PM, "Sleep disturbance in schizophrenia", Br J Psychiatry, 165, pp.697~698 (1994)
- Royuela A, "Sleep in schizophrenia : a preliminary study using the Pittsburgh Sleep Quality Index", Neurobiol Sleep-Wakefulness Cycle, 2, pp.37~39 (2002)
- Chouinard S, "Sleep in untreated patients with schizophrenia : a meta-analysis", Schizophr Bull, 30, pp.957~967 (2004)
- Association AP, "Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR" (2000), American Psychiatric Association Press
- 서호준, "수면 질환에서의 Actigraphy사용", 대한정신약물학회지, 21(4), pp.183~194 (2010), 대한정신약물학회
- Ancoli-Israel S, "The role of actigraphy in the study of sleep and circadian rhythms", Sleep, 26, pp.342~392 (2003)
- Freedson PS, "Calibration of the Computer Science and Applications, Inc. accelerometer", Med Sci Sports Exerc, 30, pp.777~781 (1998)
- 이미현, "GT1M과 GT3X가속도계의 신체활동량 추정 타당도 평가", 한국체육측정평가학회지, 14(2), pp.61~71 (2012), 한국체육측정평가학회[DOI]
- Buysse DJ, "The Pittsburgh Sleep Quality Index : a new instrument for psychiatric practice and research", Psychiatry Research, 28, pp.193~213 (1989)
- Sohn SI, "The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index", Sleep Breath, 16, pp.803~812 (2012)
- Buysse DJ, "Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical", polysomnographic measures in a community sample, 2008, pp.4, 563~571
- Johns M, "A new method for measuring daytime sleepiness", Sleep, 9, pp.519~524 (1991)
- Craig CL, "International physical activity questionnaire : 12-country reliability and validity", Med Sci Sports Exerc, 35, pp.1381~1395 (2003)
- 오지연, "한국어판 단문형 국제신처활동설문(IPAQ)의 신뢰도와 타당도", Korean Journal of Family Medicine, 28(7), pp.532~541 (2007), 대한가정의학회
- Smith CS, "Evaluation of three circadian rhythm questionnaires with suggestions for an improved measure of morningness", J Appl Psychol, 74, pp.728~ (1989)
- Yu N, "A study on the standardization of the Korean version of JA Horne and O. Ostbergs’ Morningness-Eveningness Questionnaire and on the sleep pattern", J Korean Neuropsychiatr Assoc, 34, pp.642~ (1995)
- Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Kim D, "Relationship between insight and cognitive impairment in schizophrenia", Kor J Psychopathol, 9, pp.27~35 (2000)
- Ross AJ, "Sleep efficiency and nocturnal hemodynamic dipping in young, normotensive adults", Am J Physiol Regul Integr Comp Physiol, 307, pp.R888~92 (2014)
- Brochard H, "Metabolic syndrome and actigraphy measures of sleep and circadian rhythms in bipolar disorders during remission", Acta Psychiatr Scand, 138, pp.155~162 (2018)
- Chouchou F, "Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects : the PROOF-SYNAPSE study", Eur Heart J, 34, pp.2122~2131 (2013)
- Guo X, "Epidemiological evidence for the link between sleep duration and high blood pressure : a systematic review and meta-analysis", Sleep Med, 14, pp.324~332 (2013)
- Wang Y, "Relationship between Duration of Sleep and Hypertension in Adults : A Meta-Analysis", J Clin Sleep Med, 11, pp.1047~1056 (2015)
- Fang J, "Association of sleep duration and hypertension among US adults varies by age and sex", Am J Hypertens, 25, pp.335~341 (2012)
- Nedeltcheva AV, "Metabolic effects of sleep disruption, links to obesity and diabetes", Curr Opin Endocrinol Diabetes Obes, 21, pp.293~298 (2014)
- Sabanayagam C, "Sleep duration and cardiovascular disease : results from the National Health Interview Survey", Sleep, 33, pp.1037~1042 (2010)
- van Leeuwen WM, "Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP", PLoS One, 4, pp.e4589~ (2009)
- Novati A, "Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats", Sleep, 31, pp.1579~1585 (2008)
- Meier-Ewert HK, "Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk", J Am Coll Cardiol, 43, pp.678~683 (2004)
- Kinuhata S, "Sleep duration and the risk of future lipid profile abnormalities in middle-aged men: the Kansai Healthcare Study", Sleep Med, 15, pp.1379~1385 (2014)
- Ko KJ, "The relationship between physical activity levels and metabolic syndrome in male white-collar workers", J Phys Ther Sci, 28, pp.3041~3046 (2016)
- Lee J, "Association between physical activity and the prevalence of metabolic syndrome: from the Korean National Health and Nutrition Examination Survey, 1999-2012", Springerplus, 5, pp.1870~ (2016)
- 박은옥, "제 5기 국민건강영양조사로 추정한 한국 성인의 대사증후군 유병률과 관련 요인", 농촌의학.지역보건, 38(1), pp.1~13 (2013), 한국농촌의학.지역보건학회
- Dalacorte RR, "Metabolic syndrome and physical activity in southern Brazilian community-dwelling elders: a population-based, cross-sectional study", BMC Public Health, 9, pp.25~ (2009)
- 나대웅, "중년 남성에서 대사증후군과 식이요인과의 관련성", 농촌의학.지역보건, 35(4), pp.383~394 (2010), 한국농촌의학.지역보건학회
- Bankoski A, "Sedentary activity associated with metabolic syndrome independent of physical activity", Diabetes Care, 34, pp.497~503 (2011)
- Honda T, "Sedentary bout durations and metabolic syndrome among working adults : a prospective cohort study", BMC Public Health, 16, pp.888~ (2016)
- Kahn RS, "Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder : an open randomised clinical trial", The Lancet, 371, pp.1085~1097 (2008)
- McEvoy JP, "Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison", Am J Psychiatry, 164, pp.1050~1060 (2007)
- Patel JK, "Metabolic profiles of secondgeneration antipsychotics in early psychosis : findings from the CAFE study", Schizophr Res, 111, pp.9~16 (2009)
- Meyer JM, "Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial : prospective data from phase 1", Schizophr Res, 101, pp.273~286 (2008)
- Grover S, "Prevalence of metabolic syndrome in patients with schizophrenia in India", Psychiatry Res, 200, pp.1035~1037 (2012)
- Gordon PC, "Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia", Neuropsychiatr Dis Treat, 9, pp.133~138 (2013)
- Yazici MK, "The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia : findings from a cohort in Turkey", Eur Arch Psychiatry Clin Neurosci, 261, pp.69~78 (2011)
- Monti JM, "Sleep in schizophrenia patients and the effects of antipsychotic drugs", Sleep Med Rev, 8, pp.133~148 (2004)
- Marino M, "Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography", Sleep, 36, pp.1747~1755 (2013)